PHARMASUM THERAPEUTICS AS
Operating
Pharmasum Therapeutics - Home
Utvikling, markedsføring, fremstilling/salg av farmasøytiske og
bioteknologiske produkter og andre produkter som naturlig faller
sammen med dette, herunder å delta i andre selskaper med lignende
virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg
interessert i andre foretagender.
Forskning og utviklingsarbeid innen bioteknologi og farmasi.
Links
Organization
- CEO
- AK
- Chairman of the board
- AK
- Years since formation
- 12 years
- since Jun 17, 2014
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 3,226,727
- 1 share class
- Total number of shareholders
- 684
- 194 companies, 490 persons
Financials
- Annual total result 2025
- -1,815,498
- NOK
Last update: Oct 22, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
AK | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
AK | Chairman | - |
ØS 1969 | Board Member | - |
| Board Member | - | |
RJ | Board Member | - |
TB 1961 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
KF | - | 10.95 % directly 2.98 % indirectly 7.97 % |
| - | 4.26 % directly 0.25 % indirectly 4.01 % | |
| - | 4 % indirectly | |
HT 1990 | - | 3.99 % indirectly |
HR 1978 | - | 3.99 % indirectly |
HS 1980 | - | 3.99 % indirectly |
HR 1988 | - | 3.99 % indirectly |
HH 1995 | - | 3.99 % indirectly |
HØ | - | 3.99 % indirectly |
HJ 1951 | - | 3.92 % indirectly |
Last update: Oct 22, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 900,039 | 27.89 % | |
| Ordinary shares | 258,340 | 8.01 % | |
| Ordinary shares | 257,070 | 7.97 % | |
| Ordinary shares | 103,448 | 3.21 % | |
KF | Ordinary shares | 96,307 | 2.98 % |
| Ordinary shares | 76,930 | 2.38 % | |
| Ordinary shares | 68,142 | 2.11 % | |
| Ordinary shares | 67,560 | 2.09 % | |
| Ordinary shares | 63,800 | 1.98 % | |
| Ordinary shares | 60,346 | 1.87 % | |
KH | Ordinary shares | 58,333 | 1.81 % |
| Ordinary shares | 41,941 | 1.3 % | |
SO | Ordinary shares | 41,666 | 1.29 % |
| Ordinary shares | 37,099 | 1.15 % | |
| Ordinary shares | 36,044 | 1.12 % | |
| Ordinary shares | 34,483 | 1.07 % | |
OE 1953 | Ordinary shares | 33,333 | 1.03 % |
RJ | Ordinary shares | 32,000 | 0.99 % |
| Ordinary shares | 30,000 | 0.93 % | |
| Ordinary shares | 24,800 | 0.77 % | |
| Ordinary shares | 23,362 | 0.72 % | |
GS 1944 | Ordinary shares | 21,666 | 0.67 % |
AA 1940 | Ordinary shares | 20,833 | 0.65 % |
| Ordinary shares | 20,833 | 0.65 % | |
GV | Ordinary shares | 20,833 | 0.65 % |
EV | Ordinary shares | 20,833 | 0.65 % |
JL 1943 | Ordinary shares | 20,833 | 0.65 % |
IH | Ordinary shares | 20,833 | 0.65 % |
RK | Ordinary shares | 20,833 | 0.65 % |
| Ordinary shares | 20,719 | 0.64 % | |
AØ | Ordinary shares | 20,000 | 0.62 % |
EK | Ordinary shares | 20,000 | 0.62 % |
| Ordinary shares | 17,250 | 0.53 % | |
| Ordinary shares | 16,667 | 0.52 % | |
FK 1962 | Ordinary shares | 15,892 | 0.49 % |
| Ordinary shares | 15,071 | 0.47 % | |
MD | Ordinary shares | 15,000 | 0.46 % |
PR | Ordinary shares | 14,594 | 0.45 % |
| Ordinary shares | 14,126 | 0.44 % | |
| Ordinary shares | 12,328 | 0.38 % | |
| Ordinary shares | 12,000 | 0.37 % | |
| Ordinary shares | 11,701 | 0.36 % | |
HS | Ordinary shares | 11,561 | 0.36 % |
PØ | Ordinary shares | 10,000 | 0.31 % |
AH | Ordinary shares | 10,000 | 0.31 % |
| Ordinary shares | 9,402 | 0.29 % | |
| Ordinary shares | 8,533 | 0.26 % | |
| Ordinary shares | 8,340 | 0.26 % | |
FT 1953 | Ordinary shares | 8,340 | 0.26 % |
VT 1957 | Ordinary shares | 8,333 | 0.26 % |
OF | Ordinary shares | 8,333 | 0.26 % |
| Ordinary shares | 8,307 | 0.26 % | |
| Ordinary shares | 8,127 | 0.25 % | |
| Ordinary shares | 8,094 | 0.25 % | |
| Ordinary shares | 7,700 | 0.24 % | |
G Under liquidation | Ordinary shares | 7,500 | 0.23 % |
| Ordinary shares | 7,131 | 0.22 % | |
| Ordinary shares | 6,900 | 0.21 % | |
RØ 1962 | Ordinary shares | 6,324 | 0.2 % |
| Ordinary shares | 5,758 | 0.18 % | |
| Ordinary shares | 5,616 | 0.17 % | |
| Ordinary shares | 5,395 | 0.17 % | |
| Ordinary shares | 5,150 | 0.16 % | |
RH | Ordinary shares | 5,100 | 0.16 % |
AF | Ordinary shares | 5,000 | 0.15 % |
DC | Ordinary shares | 5,000 | 0.15 % |
| Ordinary shares | 4,998 | 0.15 % | |
| Ordinary shares | 4,941 | 0.15 % | |
| Ordinary shares | 4,328 | 0.13 % | |
| Ordinary shares | 4,170 | 0.13 % | |
| Ordinary shares | 4,000 | 0.12 % | |
| Ordinary shares | 3,620 | 0.11 % | |
| Ordinary shares | 3,620 | 0.11 % | |
| Ordinary shares | 3,450 | 0.11 % | |
| Ordinary shares | 3,403 | 0.11 % | |
WJ | Ordinary shares | 3,123 | 0.1 % |
| Ordinary shares | 3,100 | 0.1 % | |
| Ordinary shares | 3,072 | 0.1 % | |
| Ordinary shares | 3,000 | 0.09 % | |
KM | Ordinary shares | 3,000 | 0.09 % |
| Ordinary shares | 2,917 | 0.09 % | |
| Ordinary shares | 2,912 | 0.09 % | |
| Ordinary shares | 2,821 | 0.09 % | |
| Ordinary shares | 2,775 | 0.09 % | |
| Ordinary shares | 2,564 | 0.08 % | |
ME | Ordinary shares | 2,564 | 0.08 % |
GG | Ordinary shares | 2,561 | 0.08 % |
| Ordinary shares | 2,560 | 0.08 % | |
S Under liquidation | Ordinary shares | 2,558 | 0.08 % |
EF | Ordinary shares | 2,500 | 0.08 % |
| Ordinary shares | 2,500 | 0.08 % | |
BK 1975 | Ordinary shares | 2,500 | 0.08 % |
| Ordinary shares | 2,500 | 0.08 % | |
| Ordinary shares | 2,445 | 0.08 % | |
NG | Ordinary shares | 2,384 | 0.07 % |
| Ordinary shares | 2,313 | 0.07 % | |
EG | Ordinary shares | 2,300 | 0.07 % |
| Ordinary shares | 2,248 | 0.07 % | |
| Ordinary shares | 2,147 | 0.07 % | |
| Ordinary shares | 2,100 | 0.07 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 989,892 | 1,379,500 | 1,520,225 | 538,481 |
Annual Total Result | -1,815,498 | -2,810,897 | -1,750,939 | -2,187,344 | -3,247,715 |
Total assets | 0 | 1,534,549 | 5,180,231 | 1,424,240 | 3,471,396 |
Total liabilities | 0 | 1,560,124 | 2,394,909 | 2,313,211 | 2,173,024 |
Total equity | 0 | -25,575 | 2,785,322 | -888,971 | 1,298,372 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 989,892 | 1,379,500 | 1,520,225 | 538,481 |
Total operating costs | 1,839,358 | 3,823,503 | 2,836,525 | 3,706,240 | 3,777,146 |
Operating result | -1,839,358 | -2,833,611 | -1,457,025 | -2,186,015 | -3,238,665 |
Financial income/costs | 23,860 | 22,714 | -293,914 | -1,328 | -9,050 |
Profit before tax | -1,815,498 | -2,810,897 | -1,750,939 | -2,187,344 | -3,247,715 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -1,815,498 | -2,810,897 | -1,750,939 | -2,187,344 | -3,247,715 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 3,224 | 16,100 | 28,976 | 0 |
Total current assets | 0 | 1,531,325 | 5,164,131 | 1,395,264 | 3,471,396 |
Total assets | 0 | 1,534,549 | 5,180,231 | 1,424,240 | 3,471,396 |
Short term debt | 0 | 491,687 | 1,326,472 | 989,807 | 849,620 |
Long term debt | 0 | 1,068,437 | 1,068,437 | 1,323,404 | 1,323,404 |
Total liabilities | 0 | 1,560,124 | 2,394,909 | 2,313,211 | 2,173,024 |
Contributed capital | 0 | 316,642 | 2,785,322 | 287,078 | 1,298,372 |
Retained earnings | 0 | -342,217 | 0 | -1,176,050 | 0 |
Total equity | 0 | -25,575 | 2,785,322 | -888,971 | 1,298,372 |
Total equity and liabilities | 0 | 1,534,549 | 5,180,231 | 1,424,240 | 3,471,396 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification